ASX 200
Checkout Our Recommendations for free - 7 day free trial Subscribe Now

Avecho Biotechnology Ltd - AVE share price

Current Price: $ - -
Updated At: -

About

Avecho Biotechnology Limited, formerly Phosphagenics Limited, is an Australia-based research-based biotechnology company. The principal activities of the Company are the development, production, sale and licensing of products incorporating its platform technology Targeted Penetration Matrix (TPM), for the pharmaceutical, skin care, and animal health and nutrition industries. The Company's segments include Production and Personal Care, and Human Health. The Production and Personal Care segment manufactures and sells TPM and Vital ET for the use in drug delivery and cosmetic formulations. The Human Health segment's portfolio covers delivery of drugs through gels, injectables and patches. The Human Health segment focuses on development of patches, including TPM/Oxymorphone and TPM/Oxycodone. The Company has various development programs under its animal health and nutrition. The Company has completed multiple studies assessing TPM as a feed additive in pigs and poultry.

Company Profile

Market Cap: -
Enterprise Value: -
Shares Outstanding: -
Shares Float: -
P/E Ratio: -
PEG Ratio: -
Book Value: -
Revenue TTM: -
Div Yield: -
Earning Share: -
Dividend per Share: -
Profit Margin: -

Disclaimer: The above financial data is sourced from EODHD and is for informational purposes only. Veye does not guarantee the accuracy or completeness of this data. Investors should conduct their own research and consult with a financial advisor before making investment decisions.

Top Shareholders

Price Summary

Today's High -
Price High
Today's Low -
Price Low
52 Week High: -
Price High
52 Week Low: -
Price Low
Price High
Week's High: -
Price Low
Week's Low: -

Price Chart

Get Your FREE Report

Discover the Top ASX Stocks to Invest In 2026!

Expert Analysis of Top-Performing ASX Stocks

Market Insights and In-Depth Research

Buy, Sell, And Hold Recommendations

Almost There!

Enter your details to download the report

Success!

Preparing your download...